+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Viaderma Inc Provides Preliminary Revenue Estimates And Highlights For Its Record Breaking 1st Quarter is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Viaderma Inc Provides Preliminary Revenue Estimates And Highlights For Its Record Breaking 1st Quarter | RobinsPost News & Noticias

Aehr Announces Preliminary Financial Results for its Fiscal 2024 Third Quarter; Provides Updated Full Year Revenue Guidance


Total revenue ... plans to release its full financial results for the fiscal 2024 third quarter on April 9, 2024, and will provide the time and conference call details in a later press release. Read More

ViaDerma, Inc. (VDRM)


LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders ... Read More

Forbes Press Releases


In this section, you’ll find the latest Forbes press releases and news announcements ... 2% to US$83.4 billion this year. Forbes releases its ninth annual Under 30 Europe List, spotlighting ... Read More

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook


March 04, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and full year ... Read More

Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023


Based upon a preliminary, unaudited review, the Company currently estimates revenue ... in this press release. In addition, the Company has not completed its fourth quarter and full-year 2023 ... Read More

PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays


Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced preliminary revenues for first-quarter 2024. Despite the soft preliminary results, the company’s shares ... Read More

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue


Management will provide ... of its financial statements for the first quarter of 2024. The financial disclosures referenced in this release for the first quarter are preliminary and are thus ... Read More

Submit Press Release Payment


The release will be posted online once funds have been cleared into our account. You will recieve an email to the registered email address with a link to the BTN article. If you have any further ... Read More

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights


Signed a development partnership with Alvogen, Inc., and Lotus Pharmaceuticals ... our upcoming filing and conference call." A final press release on the 10-k filing will be issued Monday ... Read More

Aehr Announces Preliminary Financial Results for its Fiscal 2024 Third Quarter; Provides Updated Full Year Revenue Guidance


We still expect to finish the year with near or above record annual revenue ... plans to release its full financial results for the fiscal 2024 third quarter on April 9, 2024, and will provide the ... Read More

Aehr Announces Preliminary Financial Results for its Fiscal 2024 Third Quarter; Provides Updated Full Year Revenue Guidance


Preliminary ... term gap in revenue and profitability. Additionally, Aehr provided updated revenue guidance for its full fiscal year ending May 31, 2024. For the fiscal third quarter ended ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus